Kortrijk, Belgium, 20 October 2026, 7:15 am – Today Barco (Euronext: BAR; Reuters: BARBt.BR; Bloomberg: BAR BB) announced results for the 3rd quarter ending 30 September 2026.
Third quarter 2026 highlights
- Order intake 3Q26 of 215.7 million euro, -3% versus 3Q25: orderbook of 553.9 million euro, up 3% y-o-y
- Sales 3Q26 of 228.6 million euro, including VerVent, +1% year-over-year, with growth in the Americas.
- Recurring revenues grew +6% year-over-year, reaching 13% of group sales.
Executive summary 3Q26
Sales and orders in line with last year; mixed divisional performance
in million euro
| 3Q26
| 2Q26
| 1Q26
| 4Q25
| 3Q25
| 3Q26 vs 3Q25
|
Order intake
| 215.7
| 252.4
| 215.4
| 235.7
| 222.1
| -3 %
|
Sales
| 228.6
| 237.6
| 180.6
| 282.4
| 227.1
| +1 %
|
Order intake amounted to 215.7 million euro, down 3% year-over-year. Strong Control Rooms growth and stable Healthcare performance were offset by softer Entertainment markets and lower demand in Meeting Experience. The order book remained solid at 553.9 million euro, 3% above last year.
Sales including VerVent reached 228.6 million euro, up 1% year-over-year, driven by the Americas. Recurring revenues amounted to 13% of group sales. Growth in Control Rooms was fueled by the Barco CTRL platform. The contribution from Consumer Experience compensated for lower demand in Immersive Experience and also in Cinema, which compared against a very strong quarter last year. Meeting Experience continued to see a decline in the agnostic market, while Healthcare sales were in line with last year.
Quote of the CEO, An Steegen
"In a challenging market environment, we see mixed sales patterns across divisions. Control Rooms has strong momentum, Healthcare is resilient, and Cinema will benefit from the strong summer box office. As markets are weak, we are acting by simplifying our organization, actively reviewing the portfolio and accelerating innovation and software penetration. With these clear priorities, we remain fully focused on delivering on our strategy and 2026 deliverables."
Outlook 2026
The following statements are forward looking on a like-for-like basis and actual results may differ materially
Management expects full year sales slightly below last year, with an EBITDA margin around 11%.